These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26696594)

  • 1. The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.
    Sekihara K; Hishida T; Ikemura S; Saruwatari K; Morise M; Kuwata T; Fujii S; Kojima M; Ochiai A; Funai K; Aokage K; Yoshida J; Tsuboi M; Ishii G
    J Cancer Res Clin Oncol; 2016 May; 142(5):905-12. PubMed ID: 26696594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma.
    Kaseda K; Ishii G; Aokage K; Takahashi A; Kuwata T; Hishida T; Yoshida J; Kohno M; Nagai K; Ochiai A
    Cancer Sci; 2013 Sep; 104(9):1262-9. PubMed ID: 23786153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
    Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.
    Hisakane K; Saruwatari K; Fujii S; Kirita K; Umemura S; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Kuwata T; Ochiai A; Gemma A; Tsuboi M; Goto K; Ishii G
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):593-600. PubMed ID: 26521256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
    Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K
    Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.
    Takahashi A; Ishii G; Kinoshita T; Yoshida T; Umemura S; Hishida T; Yoh K; Niho S; Goto K; Ohmatsu H; Ohe Y; Nagai K; Ochiai A
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1869-78. PubMed ID: 24013219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients.
    Maeda R; Ishii G; Neri S; Aoyagi K; Haga H; Sasaki H; Nagai K; Ochiai A
    J Thorac Oncol; 2014 Feb; 9(2):179-88. PubMed ID: 24419414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
    Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
    Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
    Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
    J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
    Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
    Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
    Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
    Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
    World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined high-grade neuroendocrine carcinoma of the lung: clinicopathological and immunohistochemical study of 34 surgically resected cases.
    Yamada K; Maeshima AM; Tsuta K; Tsuda H
    Pathol Int; 2014 Jan; 64(1):28-33. PubMed ID: 24471967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy.
    Koriyama H; Ishii G; Yoh K; Neri S; Morise M; Umemura S; Matsumoto S; Niho S; Ohmatsu H; Tsuboi M; Goto K; Ochiai A
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1163-70. PubMed ID: 25446816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
    Minami K; Jimbo N; Tanaka Y; Ogawa H; Hokka D; Nishio W; Yoshimura M; Itoh T; Maniwa Y
    J Surg Oncol; 2020 Aug; 122(2):243-253. PubMed ID: 32346887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.
    Ding L; Zhang Z; Shang D; Cheng J; Yuan H; Wu Y; Song X; Jiang H
    J Oral Pathol Med; 2014 May; 43(5):335-43. PubMed ID: 24313357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.